✦ LIBER ✦

EGFR mutation status in pleural fluid predicts tumor responsiveness and resistance to gefitinib

✍ Scribed by Soh, Junichi; Toyooka, Shinichi; Ichihara, Shuji; Suehisa, Hiroshi; Kobayashi, Naruyuki; Ito, Sachio; Yamane, Masaomi; Aoe, Motoi; Sano, Yoshifumi; Kiura, Katsuyuki; Date, Hiroshi

Book ID: 119319586
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 649 KB
Volume: 56
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2007.01.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR mutation status in tumour-derived D

EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib

✍ Kimura, H; Fujiwara, Y; Sone, T; Kunitoh, H; Tamura, T; Kasahara, K; Nishio, K 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 275 KB

Usefulness of EGFR mutation screening in

Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer

✍ Junichi Soh; Shinichi Toyooka; Keisuke Aoe; Hiroaki Asano; Syuji Ichihara; Hidek 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 467 KB 👁 2 views

## Abstract The importance of epidermal growth factor receptor (EGFR) gene mutation has been recognized in nonsmall cell lung cancer (NSCLC), requiring the standardization of mutation screening system including the kind of samples. Here, we examined the __EGFR__ mutation status in 61 pleural fluid

Detection of EGFR mutations in plasma DN

Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors

✍ Brevet, Marie; Johnson, Melissa L.; Azzoli, Christopher G.; Ladanyi, Marc 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 619 KB

Activity of pemetrexed and high-dose gef

Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib

✍ Ying Yuan, Chunwen Tan, Modan Li, Hong Shen, Xuefeng Fang, Yinghong Hu, Shenglin 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 305 KB

PD-149 Epidermal growth factor receptor

PD-149 Epidermal growth factor receptor (EGFR)-activating mutations(mut) and response to gefitinib in lung adenocarcinomas

✍ Moran, T.; de Castellanos, D.; Gomez, C.; Valero, P.; Alberola, V.; Gonzalez-Lar 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB

KRAS mutation status in colorectal cance

KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition

✍ Rouleau, E; Spyratos, F; Dieumegard, B; Guinebretière, J M; Lidereau, R; Bièche, 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 50 KB